Gland Pharma IPO — All Details
While we talk about Gland Pharma IPO, The organization headquartered in Hyderabad, Gland Pharma Ltd, is among the rapidly developing generic injectable firms. Gland Pharma Ltd, one of the fastest-growing generic injectable firms, is Hyderabad-based. It produces a sustainable set of different injectables of top standard.
The firm distributes drugs such as sterile, oncology & ophthalmic injectables, complicated injectables (peptides, suspensions, hormonal products, long-acting injectables), NCE-1s, first-to-file items, respectively. it has 7 powerful processing plants consisting of 4 finished formulations, 22 production lines, and 3 APIs in India.
Promoters of the Firm
Fosun Pharma Industrial Pte. Ltd & Shanghai Fosun Pharmaceutical Co. Ltd are promoters of the firm.
Promoters holding
- Pre Issue Share Holding- 74%
- Post Issue Share Holding — 58.3 %
Management
- Dr Ravi penmetsa (Mentor and Advisor)
- Mr. Srinivas sadu (MD & CEO),
- Mr. Kvgk Raju (CTO),
- Mr. Ravi shekhar mitra(CFO)
Gland Pharma IPO Summary
IPO Date : 09 November, 2020 to 11 November, 2020
Issue Type : Book Built Issue IPO
Issue Size: 43,196,968 Equities of Rs.1 totaling up to Rs.6,480 Cr.
Fresh Issue: 8,333,333 Equities of Rs.1 totaling up to Rs. 1,250 Cr.
Offer for Sale: 34,863,635 Equities of Rs.1 totaling up to Rs.5,230 Cr.
Face Value: Rs.1 per equity stock
IPO Price: INR 1490 to Rs.1500 per equity stock
Market Lot: 10 Stocks
Min Order Quantity: 10 Stocks
Listing At:Bombay Stock Exchange, National Stock Exchange
Basis of Allotment
Qualified Institutional Buyer Around : 50%
Non Institutional Investor : 15%
Retail: 35% (Minimal level of 1 lot, based on availability, for every shareholder.)
Gland Pharma IPO‘s Tentative dates
Bid/Offer start date: 09 November, 2020
Bid/Offer end date: 11 November, 2020
Allotment finalization date: 17 November, 2020
Refunds starting from: 18 November, 2020
Shares to be credited in Demat Account: 19 November, 2020
Listing Date for IPO: 20 November, 2020
Purpose of the Gland Pharma IPO:
For the specified objectives, funds raised from the Grand Pharma IPO would be utilised:
- Financing the firm’s additional working capital commitments
- Meeting the funding criteria for the standards for capital expenditure
- To achieve basic organisational goals
Gland Pharma IPO Proposal
Gland Pharma Official Contact Details
Gland Pharma Limited
Survey №143–148, 150 & 151
Near Gandimaisamma ‘X’ Roads
D.P. Pally, Dundigal Gandimaisamma Mandal
Medchal-Malkajgiri District
Hyderabad 500043, Telangana, India
Ph: +91 40 3051 0999, Fax: +91–40–30510800
Email ID: investors@glandpharma.com
Web: http://www.glandpharma.com
Registrar
Link Intime India Private Limited
C-101, 1st Floor, 247 Park Lal Bahadur Shastri Marg, Vikhroli (West)
Mumbai — 400 083
Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: glandpharma.ipo@linkintime.co.in
Website: http://www.linkintime.co.in
Gland Pharma IPO managers
- Citigroup Global Markets India Private Limited
- Haitong Securities India Private Limited
- Kotak Mahindra Capital Company Limited
- Nomura Financial Advisory And Securities (India) Pvt Ltd
Positive Points for Gland Pharma IPO
- A comprehensive product selection of specific injectables.
- India ‘s diversified B2B structure with a focused B2c market.
- Good ability for growth.
- Reliable performance history financially.
- An established and qualified team of management.
Negative Points for Gland Pharma IPO
- ED had attached some shares of one promoter in a old ongoing legal issue.
- Margins are on very high levels.
Grey Market Premium
While we talk about Grey market Premium it is nearly 10% as of now. However, We will update you on daily basis till the time the IPO get listed.
Conclusion:
Throughout the last 3 years, Gland Pharma had good income performance. As among the country’s biggest pharma company most buyers wish to be a part of its company’s growth. Read and understand through the profitability of a business and the Red Herring Prospectus (RHP) thoroughly before investing.
Please also a advise of your financial adviser before investing as they are many risk involve in share market. We hope we are able to answer all you questions about In Gland Pharma IPO.
